Your browser doesn't support javascript.
loading
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.
Luoma, Adrienne M; Suo, Shengbao; Williams, Hannah L; Sharova, Tatyana; Sullivan, Keri; Manos, Michael; Bowling, Peter; Hodi, F Stephen; Rahma, Osama; Sullivan, Ryan J; Boland, Genevieve M; Nowak, Jonathan A; Dougan, Stephanie K; Dougan, Michael; Yuan, Guo-Cheng; Wucherpfennig, Kai W.
Afiliação
  • Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
  • Suo S; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.
  • Williams HL; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA.
  • Sharova T; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Sullivan K; Division of Gastroenterology and Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA.
  • Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Bowling P; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Rahma O; Department of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02215, USA; Brigham and Women's Hospital and Dana-Farber/Harvard Cancer Center, Boston, MA, USA.
  • Sullivan RJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Boland GM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Nowak JA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA.
  • Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
  • Dougan M; Division of Gastroenterology and Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA. Electronic address: mldougan@partners.org.
  • Yuan GC; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA.
  • Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Neurology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. Electronic address: k
Cell ; 182(3): 655-671.e22, 2020 08 06.
Article em En | MEDLINE | ID: mdl-32603654
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite / Linfócitos T CD8-Positivos / Receptores de Quimiocinas / Células Mieloides / Antígeno CTLA-4 / Inibidores de Checkpoint Imunológico / Imunoterapia Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite / Linfócitos T CD8-Positivos / Receptores de Quimiocinas / Células Mieloides / Antígeno CTLA-4 / Inibidores de Checkpoint Imunológico / Imunoterapia Idioma: En Ano de publicação: 2020 Tipo de documento: Article